Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile.

about

Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile.

Item

http://www.wikidata.org/entity/Q47661367

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Refined karyotype-based progno ...... very-low-risk genetic profile.

@en

Refined karyotype-based progno ...... very-low-risk genetic profile.

@nl

type

Item

label

Refined karyotype-based progno ...... very-low-risk genetic profile.

@en

Refined karyotype-based progno ...... very-low-risk genetic profile.

@nl

prefLabel

Refined karyotype-based progno ...... very-low-risk genetic profile.

@en

Refined karyotype-based progno ...... very-low-risk genetic profile.

@nl

P1476

Refined karyotype-based progno ...... very-low-risk genetic profile.

@en

P2093

A Bardi

http://www.w3.org/2001/XMLSchema#string

A Cuneo

http://www.w3.org/2001/XMLSchema#string

A Guarini

http://www.w3.org/2001/XMLSchema#string

A Piciocchi

http://www.w3.org/2001/XMLSchema#string

C Ilari

http://www.w3.org/2001/XMLSchema#string

D Rossi

http://www.w3.org/2001/XMLSchema#string

E Saccenti

http://www.w3.org/2001/XMLSchema#string

E Tammiso

http://www.w3.org/2001/XMLSchema#string

E Volta

http://www.w3.org/2001/XMLSchema#string

F R Mauro

http://www.w3.org/2001/XMLSchema#string

P2860

Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.

Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations

Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.

Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

P2888

leu.2017.292

P31

scholarly article

P356

10.1038/LEU.2017.292

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28924243

http://www.w3.org/2001/XMLSchema#string

P921

karyotype

lymphocyte

P932

5898432

http://www.w3.org/2001/XMLSchema#string